Aprotinin polypeptides for transporting a compound across the blood-brain barrier

Details for Australian Patent Application No. 2012204135 (hide)

Owner Angiochem, Inc.

Inventors Beliveau, Richard; Demeule, Michel; Che, Christian; Regina, Anthony

Agent FB Rice

Pub. Number AU-A-2012204135

Parent 2005327497

Filing date 12 July 2012

Wipo publication date 2 August 2012

International Classifications

C12N 15/15 Mutation or genetic engineering - Protease inhibitors, e.g. antithrombin, antitrypsin, hirudin

A61K 47/42 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/14 Preparations for testing

A61K 51/08 Preparations containing radioactive substances for use in therapy or testing

A61P 25/00 Drugs for disorders of the nervous system

C07K 14/81 Peptides having more than 20 amino acids - Protease inhibitors

Event Publications

26 July 2012 Complete Application Filed

2 August 2012 Application Open to Public Inspection

  Published as AU-A-2012204135

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012204136-Method for removal of organic compounds from waste water streams in a process for production of (meth)acrylic acid

2012204134-An electronic method of providing an additional player reward and a gaming system